Use of biomarkers in the management of febrile neutropenia episodes in children with cancer.
作者信息
de Oliveira Benigna Maria
机构信息
Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
出版信息
Rev Bras Hematol Hemoter. 2016 Apr-Jun;38(2):93-4. doi: 10.1016/j.bjhh.2015.10.006. Epub 2015 Dec 30.
Abstract
摘要
相似文献
1
Use of biomarkers in the management of febrile neutropenia episodes in children with cancer.生物标志物在癌症患儿发热性中性粒细胞减少症发作管理中的应用。
Rev Bras Hematol Hemoter. 2016 Apr-Jun;38(2):93-4. doi: 10.1016/j.bjhh.2015.10.006. Epub 2015 Dec 30.
2
Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.用于预防急性淋巴细胞白血病患儿骨髓抑制治疗所致发热性中性粒细胞减少症的集落刺激因子
Cochrane Database Syst Rev. 2005 Jul 20(3):CD004139. doi: 10.1002/14651858.CD004139.pub2.
3
A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.一项关于癌症患儿化疗引起的中性粒细胞减少期间或造血干细胞移植后发热发作流行病学的前瞻性研究。
Clin Infect Dis. 2007 Nov 15;45(10):1296-304. doi: 10.1086/522533. Epub 2007 Oct 5.
4
Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.患有癌症和中性粒细胞减少症的发热儿童的血清白细胞介素-1β、可溶性白细胞介素-2受体、白细胞介素-6、白细胞介素-8和肿瘤坏死因子-α水平。
Med Oncol. 2001;18(1):51-7. doi: 10.1385/MO:18:1:51.
5
6
The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.降钙素原、C反应蛋白、可溶性髓系细胞触发受体-1及前降钙素在儿童发热性中性粒细胞减少症血流感染中的预测价值。 （注：原文中“presepsin”可能有误，正确的是“soluble triggering receptor expressed on myeloid cells-1，sTREM-1”，即可溶性髓系细胞触发受体-1，译文按纠正后的内容翻译）
Turk J Pediatr. 2019;61(3):359-367. doi: 10.24953/turkjped.2019.03.007.
7
Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.每日一次使用头孢曲松和庆大霉素治疗发热性中性粒细胞减少症。
Arch Dis Child. 1999 Feb;80(2):125-31. doi: 10.1136/adc.80.2.125.
8
Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.降钙素原和白细胞介素-6 对癌症合并发热性中性粒细胞减少症患儿细菌感染的预测价值。
Support Care Cancer. 2018 Nov;26(11):3819-3826. doi: 10.1007/s00520-018-4249-3. Epub 2018 May 19.
9
A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period.一项为期 5 年的阿根廷 515 例发热性中性粒细胞减少症的多中心前瞻性研究。
PLoS One. 2019 Oct 31;14(10):e0224299. doi: 10.1371/journal.pone.0224299. eCollection 2019.
10
Predictive value of higher plasma interleukin-6 levels in patients with febrile neutropenia.发热性中性粒细胞减少症患者血浆白细胞介素-6水平升高的预测价值。
Arch Med Res. 2002 Nov-Dec;33(6):557-61. doi: 10.1016/s0188-4409(02)00415-0.
本文引用的文献
1
Could CD64 expression be used as a predictor of positive culture results in children with febrile neutropenia?CD64表达能否作为发热性中性粒细胞减少症患儿培养结果阳性的预测指标？
Rev Bras Hematol Hemoter. 2015 Nov-Dec;37(6):395-9. doi: 10.1016/j.bjhh.2015.08.011. Epub 2015 Oct 9.
2
Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs.在不到60分钟内接受抗生素治疗发热和中性粒细胞减少症的儿科患者对重症监护的需求减少。
Pediatr Blood Cancer. 2015 May;62(5):807-15. doi: 10.1002/pbc.25435. Epub 2015 Feb 7.
3
Management of fever and neutropenia in children with cancer.癌症患儿发热与中性粒细胞减少的管理
Support Care Cancer. 2015 Jul;23(7):2079-87. doi: 10.1007/s00520-014-2572-x. Epub 2014 Dec 23.
4
Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.门诊与住院 IV 抗生素管理在儿科肿瘤患者低危发热性中性粒细胞减少症中的应用：一项随机试验。
Pediatr Blood Cancer. 2014 Aug;61(8):1427-33. doi: 10.1002/pbc.25012. Epub 2014 Mar 6.
5
Prospective validation of a risk prediction model for severe sepsis in children with cancer and high-risk febrile neutropenia.癌症患儿和高危发热性中性粒细胞减少症患儿严重脓毒症风险预测模型的前瞻性验证
Pediatr Infect Dis J. 2013 Dec;32(12):1318-23. doi: 10.1097/01.inf.0000436128.49972.16.
6
An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer.血清生物标志物在评估癌症中性粒细胞减少症儿童发热中的预测价值的更新系统评价和荟萃分析。
Pediatr Infect Dis J. 2013 Oct;32(10):e390-6. doi: 10.1097/INF.0b013e31829ae38d.
7
Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation.儿童癌症患者和/或接受造血干细胞移植后发热与中性粒细胞减少的管理指南。
J Clin Oncol. 2012 Dec 10;30(35):4427-38. doi: 10.1200/JCO.2012.42.7161. Epub 2012 Sep 17.
8
9
Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia.预测化疗引起的发热性中性粒细胞减少症儿童发生严重细菌感染的风险。
Pediatr Blood Cancer. 2010 Oct;55(4):662-7. doi: 10.1002/pbc.22586.
Zotero 插件